Items tagged with Access
Advocates demand immediate national roll out of 3HP in India (post with simple image)
Community monitoring mechanism highlights the gaps in the existing isoniazid preventive therapy program in the country and clearly indicates the high demand for 3HP.
Community-led monitoring for access to TB screening and diagnostic testing (post with simple image)
A tool, developed by the Coalition of Women Living with HIV and AIDS in partnership with Treatment Action Group, designed to equip communities to use community-lead monitoring to better understand the TB screening and diagnostic services, and to translate findings into evidence-based advocacy.
Activists across the world demand urgent action to improve access to lifesaving TB medicine, bedaquiline (post with simple image)
Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.
TB CAB 10-year anniversary evaluation report 2011–2021 and podcast (post with simple image)
In 2021, TB CAB celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.
Partners announce reduced price for patient-friendly TB preventive treatments (post with simple image)
Partners announce two new agreements to lower the price of rifapentine-based treatments to prevent TB in low- and middle-income countries.
Advocates reiterate their demand for immediate national roll out of 3HP in India (post with simple image)
Community monitoring mechanism highlights the gaps in the existing isoniazid preventive therapy program in the country and clearly indicates the high demand for 3HP.
MSF warns that supply delays of critical TB test will cost lives (post with simple image)
A shortage of TB tests at this critical juncture will be disastrous.
Updates required to the National TB guidelines to support access to shorter regimens as a human right in India (post with simple image)
Advocates demand that the Indian government take urgent action to ensure that every eligible person with TB has access to evidence-based, short-course treatment regimens.
Response to TB treatment trials results published and presented during the 2022 Union World Conference on Lung Health (post with simple image)
Statement by Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB)
New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk (post with simple image)
With newer TB drugs to go off patent in 2023, MSF calls on Johnson & Johnson, Otsuka, and TB Alliance to remove additional barriers blocking generic manufacturers from entering the market.
Page 78 of 83 · Total posts: 0
←First 77 78 79 Last→